Subsensitivity to Bronchoprotection Against Adenosine Monophosphate Challenge Following Regular Once-Daily Formoterol

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.98.12030580
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Thorax
PulmonaryRespiratory Medicine
2010English

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Thorax
PulmonaryRespiratory Medicine
2015English

Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2019English

The Arginine-16 Β2-Adrenoceptor Polymorphism Predisposes to Bronchoprotective Subsensitivity in Patients Treated With Formoterol and Salmeterol

British Journal of Clinical Pharmacology
Pharmacology
2003English

Synthesis of Α-Adenosine 5'-Monophosphate

Agricultural and Biological Chemistry
1967English

Tularemia and Once-Daily Gentamicin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT)

Transplantation
Transplantation
2013English

The Stable Cyclic Adenosine Monophosphate Analogue, Dibutyryl Cyclo-Adenosine Monophosphate (Bucladesine), Is Active in a Model of Acute Skin Inflammation

Archives of Dermatological Research
DermatologyMedicine
2012English

Airway Responsiveness to Adenosine 5′-Monophosphate and Exhaled Nitric Oxide Measurements

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy